TrialJournal of bone and mineral metabolism2012

Alfacalcidol-supplemented raloxifene therapy has greater bone-sparing effect than raloxifene-alone therapy in postmenopausal Japanese women with osteoporosis or osteopenia.

Itsuo Gorai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.